Skip to main content

Chromosome abnormalities




Epithelial cells, which line many body surfaces, can transform into several types of cancer. These transformed cancer cells often have an abnormal number of chromosomes, either more or less than the standard 23 pairs of chromosomes. This condition, called aneuploidy, is a hallmark of cancer, and it is commonly seen in breast cancer.

A few studies in recent years have used advanced genetic sequencing techniques to detect small numbers of aneuploid cells in normal body tissues, including the brain, colon, liver, lymphocytes, and sperm. But the significance of these rare aneuploid cells in healthy tissues is not well understood.

A research team led by Dr. Nicholas Navin of the University of Texas MD Anderson Cancer Center set out to learn about the prevalence and potential impact of aneuploid epithelial cells in normal breast tissue. They analyzed breast epithelial cells from 49 women who were undergoing breast reduction surgery. All of the women were healthy and had no signs of breast cancer. Their ages ranged from 18 to 63.

The researchers used a combination of advanced sequencing techniques to assess chromosome additions and deletions in more than 83,000 breast epithelial cells from these women. They then compared their findings to previously gathered data from women who had invasive breast cancer. Study results appeared in Nature on November 20, 2024.

The researchers found that all of the 49 healthy women harbored rare aneuploid epithelial cells in their breast tissue. A median of about 3% of the tested cells in each woman were aneuploid. The number of aneuploid epithelial cells in each woman tended to increase with age. Most of these abnormal cells (median more than 80%) had undergone significant chromosomal changes, many of which are seen in invasive breast cancers.

The findings suggest that most healthy women have low levels of aneuploid cells in their breast tissues. Additional studies are needed to determine if increased levels of these rare cells raise the risk for future breast cancer. In addition, the researchers note that their findings might also be applicable to other organs and tissues that contain epithelial cells.

“We’ve always been taught that normal cells have 23 pairs of chromosomes. But that appears to be inaccurate because every healthy woman that we analyzed in our study had irregularities, bringing up the very provocative question about when cancer actually occurs,” Navin says. “This has pretty big implications not just for the field of breast cancer, but potentially for multiple cancer types.”

congenital disorders, genetic mutations, chromosomal abnormalities, birth defects, developmental delay, neurological disorders, metabolic disorders, structural anomalies, rare diseases, prenatal diagnosis, hereditary conditions, gene expression, syndromic features, phenotype variation, molecular abnormalities, clinical manifestations, diagnostic imaging, pathophysiology, cellular dysfunction,

#abnormalities, #geneticdisorders, #birthdefects, #neurologicalabnormalities, #congenitaldisorders, #chromosomalanomalies, #raredisease, #developmentaldelay, #prenataldiagnosis, #moleculargenetics, #clinicalresearch, #genemutation, #phenotypevariation, #medicalgenetics, #structuraldisorders, #epigenetics, #diagnosticimaging, #metabolicdisorders, #healthresearch, and #cellulardysfunction


International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

Comments

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...